Abstract
The calcineurin inhibitor cyclosporine A (CsA) improves survival in endotoxemic mice. It was hypothesized that CsA counteracts the bradycardia and hypotension characteristic of endotoxemia. Vascular reactivity was determined in lipopolysaccharide (LPS; 50 μg/mL)-treated mouse aortic rings suspended in a myograph. Arterial blood pressure and heart rate were measured continuously with indwelling catheters in conscious mice treated with CsA and a bolus injection of LPS (2 mg/kg). The α1-adrenoceptor agonist phenylephrine induced stable tension of aortic rings that were attenuated significantly by LPS. Co-incubation of rings with LPS and CsA (1 × 10−7 mol/L–1 × 10−5 mol/L) restored vascular reactivity to phenylephrine. Intravenous administration of CsA (20 and 40 mg/kg/day) to mice induced a significant increase (by approximately 10 mmHg) in mean arterial blood pressure (MAP), with no effect on heart rate. An LPS bolus led to significant decreases in MAP (by approximately 30 mmHg) and heart rate (to 50 % of baseline). CsA-treated LPS-mice exhibited higher MAP at some (20 mg/kg) or all (40 mg/kg) time points after LPS. The decrease in MAP (Δ pressure) was similar between vehicle- and CsA-treated groups. The 50 % decrease in heart rate was not affected by CsA. Inducible nitric oxide synthase (iNOS) mRNA and protein levels in LPS-treated mice organs and plasma NO x concentration were significantly reduced by CsA. It is concluded that in a murine model of endotoxemia, increased peripheral vascular resistance and suppression of systemic NO formation by cyclosporine A are not sufficient to prevent cardiovascular collapse, which is caused primarily by compromised cardiac function.
Similar content being viewed by others
References
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
Avontuur JA, Tutein Nolthenius RP, Van Bodegom JW, Bruining HA (1998) Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med 26:660–667
Balibrea JM, Garcia-Martin MC, Cuesta-Sancho S, Olmedilla Y, Arias-Diaz J, Fernandez-Sevilla E, Vara E, Balibrea JL (2011) Tacrolimus modulates liver and pancreas nitric oxide synthetase and heme-oxygenase isoforms and cytokine production after endotoxemia. Nitric Oxide 24:113–122
Barth E, Radermacher P, Thiemermann C, Weber S, Georgieff M, Albuszies G (2006) Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 34:307–313
Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S (1998) Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med 24:1315–1322
Brodde OE, Adamczyk M, Busch F, Bossaller C, Duske E, Fleck E, Gotze S, Auch-Schwelk W (1995) Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 25:761–767
Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P (2006) Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116:2244–2251
Connelly L, Madhani M, Hobbs AJ (2005) Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived no in vivo. J Biol Chem 280:10040–10046
Dusting GJ, Akita K, Hickey H, Smith M, Gurevich V (1999) Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. Br J Pharmacol 128:337–344
Ellrodt AG, Riedinger MS, Kimchi A, Berman DS, Maddahi J, Swan HJ, Murata GH (1985) Left ventricular performance in septic shock: reversible segmental and global abnormalities. Am Hear J 110:402–409
Fruman DA, Klee CB, Bierer BE, Burakoff SJ (1992) Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A 89:3686–3690
Hahn PY, Wang P, Tait SM, Ba ZF, Reich SS, Chaudry IH (1995) Sustained elevation in circulating catecholamine levels during polymicrobial sepsis. Shock 4:269–273
Hallemeesch MM, Janssen BJ, De Jonge WJ, Soeters PB, Lamers WH, Deutz NE (2003) NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am J Physiol 285:E871–875
Hamalainen M, Korhonen R, Moilanen E (2009) Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA. Int Immunopharmacol 9:159–167
Hamalainen M, Lahti A, Moilanen E (2002) Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. Eur J Pharmacol 448:239–244
Hattori Y, Nakanishi N (1995) Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell Immunol 165:7–11
Jennings C, Kusler B, Jones PP (2009) Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo. Innate Immun 15:109–120
Laubach VE, Shesely EG, Smithies O, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92:10688–10692
Lee J, Kim SW, Kook H, Kang DG, Kim NH, Choi KC (1999) Effects of L-arginine on cyclosporin-induced alterations of vascular NO/cGMP generation. Nephrol Dial Transplant 14:2634–2638
Liu J, Albers MW, Wandless TJ, Luan S, Alberg DG, Belshaw PJ, Cohen P, Mackintosh C, Klee CB, Schreiber SL (1992) Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31:3896–3901
Long C, Cook LG, Hamilton SL, Wu GY, Mitchell BM (2007) FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 49:569–576
Lopez A, Lorente JA, Steingrub J, Bakker J, Mcluckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21–30
Macmicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641–650
Mottram PL, Mirisklavas A, Mason A, Dumble LJ, Smith JA, Clunie GJ, Panagiotopoulos S, Nayler WG (1989) Immunosuppressive and cardiotoxic effects of cyclosporine in CBA mice. Transplantation 48:720–723
Obias VJ, Rushing GD, Prewitt RL, Rice D, Britt LD (2006) Cyclosporine inhibits endotoxin-induced vasodilation of isolated rat resistance arterioles. J Surg Res 136:112–115
Rego A, Vargas R, Cathapermal S, Kuwahara M, Foegh ML, Ramwell PW (1991) Systemic vascular effects of cyclosporin A treatment in normotensive rats. J Pharmacol Exp Ther 259:905–915
Rego A, Vargas R, Suarez KR, Foegh ML, Ramwell PW (1990) Mechanism of cyclosporin potentiation of vasoconstriction of the isolated rat mesenteric arterial bed: role of extracellular calcium. J Pharmacol Exp Ther 254:799–808
Rusnak F, Mertz P (2000) Calcineurin: form and function. Physiol Rev 80:1483–1521
Staehr M, Madsen K, Vanhoutte PM, Hansen PB, Jensen BL (2011) Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings. Am J Physiol Regul Integr Comp Physiol 301:R412–420
Stein B, Frank P, Schmitz W, Scholz H, Thoenes M (1996) Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28:1631–1639
Tang C, Liu MS (1996) Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis. Am J Physiol 270:R254–263
Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408–411
Winslow MM, Gallo EM, Neilson JR, Crabtree GR (2006) The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity 24:141–152
Acknowledgements
We thank Vivi Monrad, Lis Teusch and Kenneth Andersen for expert technical assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
This work was supported by The Danish Heart Association; The Novo Nordisk Foundation; Alfred Andersens Fund; The Danish Research Council for Health and Disease; The Danish Cardiovascular Research Academy; The AP Møller Foundation and Leo Pharma´s Hypertensionslegat.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stæhr, M., Khatam-Lashgari, A., Vanhoutte, P.M. et al. The calcineurin inhibitor cyclosporine A improves lipopolysaccharide-induced vascular dysfunction but does not rescue from cardiovascular collapse in endotoxemic mice. Pflugers Arch - Eur J Physiol 465, 1467–1475 (2013). https://doi.org/10.1007/s00424-013-1290-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-013-1290-4